However, this study was limited due to the lack of a mouse model to validate the relationship between exosome PD-L1 and tumor immunity in vivo and whether inhibiting exosomal PD-L1 can improve immune activation targeting GC. This evidence concerns the gene CD274 and gastric cancer.